FHTXVSGTBP• 6 Months (Normalized)
FHTX vs GTBP (Foghorn Therapeutics Inc. vs GT Biopharma Inc.)
Showing Closing Date Range from Apr 9 to Oct 6, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
FHTX Performance $1.97
-58.87%
Foghorn Therapeutics Inc.
Normalized Baseline0.00%
GTBP Performance $6.37
+1533.33%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-1592.2 pts
GTBP outperforming by 1592.20 percentage points
FHTXGTBP
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
FHTX GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(125 dates)
| Date | FHTX Price | FHTX Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 06, 2026 | $1.97 | -58.87% | $6.37 | +1533.33% | -1592.20% |
| Oct 05, 2026 | $2.00 | -58.25% | $6.16 | +1479.49% | -1537.74% |
| Oct 02, 2026 | $2.02 | -57.83% | $6.10 | +1464.10% | -1521.93% |
| Oct 01, 2026 | $2.92 | -39.04% | $- | - | |
| Sep 30, 2026 | $3.57 | -25.47% | $- | - | |
| Sep 29, 2026 | $- | $6.88 | +1662.82% | - | |
| Sep 28, 2026 | $- | $6.80 | +1643.59% | - | |
| Sep 25, 2026 | $3.54 | -26.09% | $6.89 | +1666.67% | -1692.76% |
| Sep 24, 2026 | $3.60 | -24.84% | $6.83 | +1651.28% | -1676.12% |
| Sep 23, 2026 | $3.87 | -19.21% | $7.10 | +1720.51% | -1739.72% |
| Sep 22, 2026 | $4.24 | -11.48% | $- | - | |
| Sep 21, 2026 | $4.15 | -13.36% | $7.18 | +1741.03% | -1754.39% |
| Sep 18, 2026 | $4.14 | -13.57% | $7.16 | +1735.90% | -1749.47% |
| Sep 17, 2026 | $4.20 | -12.32% | $7.49 | +1820.51% | -1832.83% |
| Sep 16, 2026 | $4.17 | -12.94% | $7.81 | +1902.56% | -1915.50% |
Page 1 of 9